TrialsgrambetaRCTs are beautiful

CORP-2

2014

COlchicine for Recurrent Pericarditis 2 — multiple recurrences

In 240 patients with at least two prior recurrences of pericarditis, colchicine for 6 months added to conventional anti-inflammatory therapy reduced further recurrent pericarditis compared with placebo.

Result

Efficacy: Recurrent pericarditis (intention-to-treat)RR 0.49 (95% CI 0.24-0.65) · P = 0.0009

Below 1 favours colchicine for 6 months added to conventional anti-inflammatory therapy, above 1 favours placebo.

Event rates
Absolute difference
20.9 points
NNT
5

Absolute difference and NNT are derived from the event rates.

Also reported: NNT 5). No serious adverse events.

Original publication
Subtopic
Recurrent pericarditis
Design
Double-blind, placebo-controlled RCT
Relevance
Important: one of several pillars.
Source
Imazio M, Belli R, Brucato A, et al. Lancet. 2014;383(9936):2232-2237.doi 10.1016/S0140-6736(13)62709-9

Discussion & critique

Four northern-Italian hospitals and a predominantly idiopathic case mix, with open follow-up beyond six months limiting inference about optimal duration. It closed the last gap in the colchicine story and extends the drug to every colchicine-naïve relapse, however many have gone before.